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Summary
The p66Shc adaptor protein is an important regulator of lifespan
in mammals, but the mechanisms responsible are still unclear.
Here, we show that expression of p66Shc, p52Shc, and p46Shc is
regulated at the post-transcriptional level by the microRNA
let-7a. The levels of let-7a correlated inversely with the levels
of Shc proteins without affecting Shc mRNA levels. We identified
‘seedless’ let-7a interaction elements in the coding region of Shc
mRNA; mutation of the ‘seedless’ interaction sites abolished the
regulation of Shc by let-7a. Our results further revealed that
repression of Shc expression by let-7a delays senescence of
human diploid fibroblasts (HDFs). In sum, our findings link let-7a
abundance to the expression of p66Shc, which in turn controls
the replicative lifespan of HDFs.
Key words: cellular lifespan; let-7a; p66Shc; replicative senes-
cence; translational regulation.
Introduction
Animal longevity is controlled by multiple molecular mechanisms,
involving genes such as the silent information regulator SIRT1 (Bordone
& Guarente, 2005), superoxide dismutases (SOD1 and SOD2; Fabrizio
et al., 2003; Parker et al., 2004), p66Shc (Migliaccio et al., 1999;
Pinton & Rizzuto, 2008), as well as insulin and insulin-like growth
factor-1 (IGF-1; Yang et al., 2005). p66Shc is one of the members of
the Shc family of proteins consisting of three isoforms (p66Shc,
p52Shc, and p46Shc) that arise through alternative initiation of
translation (Luzi et al., 2000). p52Shc and p46Shc were found in every
cell type with invariant reciprocal relationship, while p66Shc expression
varies in different cell type, suggesting that the function of p66Shc may
be different from those of p52Shc/p46Shc (Migliaccio et al., 1997).
Initially, all three isoforms of Shc were recognized as ‘adaptor’ proteins
forming a complex with Grb2, an adaptor protein in the Ras signaling
pathway. However, unlike p52Shc and p46Shc, p66Shc has little effect
on the Ras signal pathway (Migliaccio et al., 1997). Instead, p66Shc has
been described as a regulator for the longevity of mammals. p66Shc/
mice exhibited longer lifespan that was probably due to decreased
cardiac diseases and reduced reactive oxygen species (ROS) production
(Migliaccio et al., 1999; Napoli et al., 2003). However, the role of
p66Shc in regulating other age-related processes has not been
elucidated.
In response to oxidative stress, part of the cytosolic p66Shc
translocates to the mitochondria and acts as an oxidoreductase.
Phosphorylation at serine 36 by PKC is essential for its translocation,
because a serine-phosphorylation defective mutant of p66Shc cannot
restore the normal stress response in p66Shc/ cells (Migliaccio et al.,
1999). On the other hand, elevation of p66Shc protein has been
observed in primary human prostate tumors (Veeramani et al., 2005), in
replicative senescence (Zhang et al. 2010), in middle-aged mice
(Lebiedzinska et al., 2009), as well as in cells exposed to oxidative stress
and UVC (Favetta et al., 2004). Regulation of p66Shc at transcriptional
level by p53 and DNA methylation has been described (Trinei et al.,
2002; Ventura et al., 2002). However, the regulation of p66Shc in
replicative senescence remains largely unknown.
In this study, we show that microRNA let-7a regulates lifespan of
human diploid fibroblasts by repressing the translation of p66Shc. We
describe that let-7a interacts with ‘seedless’ sites located in the coding
region (CR) of p66Shc mRNA, prevents the association p66Shc mRNA
with the polysome, and enhances the recruitment of p66Shc mRNA into
PBs, thereby repressing the translation of p66Shc. These studies reveal a
novel microRNA-mediated mechanism linking p66Shc and cellular
lifespan.
Results
let-7 represses the translation of p66Shc, p52Shc, and p46Shc
This study was initiated from our findings that intervention of the let-
7a levels altered the levels of p66Shc, p52Shc, and p46Shc proteins.
Western blot analysis revealed that overexpression of let-7a by
transfecting a vector that expressed pre-let-7a in IDH4 cells reduced
p66Shc, p52Shc, and p46Shc proteins by ~50–70% (Fig. 1A), while
knockdown of let-7a by transfecting a vector expressing let-7a
antisense (AS-let-7a) increased Shc proteins by ~2.3- to 5.6-fold
(Fig. 1B). IDH4 cells are derived from senescent IMR-90 cells, but
through constitutive, dexamethasone (dex)-driven SV40 large T-anti-
gen, IDH4 cells can proliferate in culture; upon dex removal from the
medium, cells rapidly return to senescence (Wright et al., 1989). In
contrast, neither knockdown nor overexpression of miR-30 substan-
tially altered the expression of p66Shc, p52Shc, and p46Shc. To
further address the mechanism by which let-7a regulates the
expression of Shc proteins, the levels of p66Shc mRNA in cells
described in Fig. 1(A,B) were analyzed by reverse-transcription (RT)
followed by real-time, quantitative (q)PCR analysis. p52Shc and
p46Shc were translated from the same transcript as p66Shc (p66Shc
mRNA), by alterative initiation of translation (Fig. S1). The levels of
p66Shc mRNA, which could potentially be used for synthesis of all Shc
proteins, were not substantially altered by modulating let-7a or miR-
30 abundance (Fig. 1C), suggesting that let-7a does not affect Shc
expression at the level of mRNA turnover and instead may affect Shc
translation. To test this hypothesis, IDH4 cells transiently expressing
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antisense let-7a or antisense miR-30 were incubated in medium
containing L-[35S] methionine and L-[35S] cysteine for 20 min, cell
lysates were then prepared and subjected to immunoprecipitation to
analyze the level of nascent Shc proteins. As shown in Fig. 1(D),
nascent Shc protein synthesis in AS-let-7a-expressing cells was ~3.2-
to 4.1-fold higher than what was observed in control cells, while Shc
translation in AS-miR-30-expressing cells was comparable with that
measured in control cells. In control reactions, knockdown of let-7a or
miR-30 did not influence the levels of nascent GAPDH. These results
support the idea that let-7a represses the translation of p66Shc,
p52Shc, and p46Shc.
To further investigate the repression of p66Shc, p52Shc, and
p46Shc by let-7a, we examined the involvement of the Ago2-
containing RNA/microRNA-induced silencing complex (RISC). HeLa cells
were transfected with siRNA targeting Ago2 or let-7a, or co-
transfected with both siRNAs, whereupon the levels of Shc proteins
were assessed by Western blot analysis. As shown in Fig. 1(E),
knockdown of Ago2 and let-7a increased the levels of Shc proteins
by ~2.2–3.8- and ~2.5–3.9-fold, respectively, while simultaneous
knockdown of Ago2 and let-7a did not show further effect of
elevating Shc protein levels. These results support the view that let-7a
represses the translation of p66Shc, p52Shc, and p46Shc in an Ago2/
RISC-dependent manner.
We also assessed the expression of Shc proteins in cells transfecting
with the siRNA or inhibitor of let-7a. As shown in the Fig. S2(A),
transfection of IDH4 cells with let-7a siRNA, but not miR-30 siRNA,
elevated the levels of Shc proteins. Transfection of IDH4 cells with an
inhibitor of let-7a increased the levels of Shc proteins; transfection of
cells with let-7b inhibitor moderately induced the Shc protein levels (Fig.
S2B). In addition, transfection of cells with inhibitor of let-7c, let7d, miR-
9, miR-22, or miR-30 did not alter the levels of Shc proteins (Fig. S2B,C).
These results confirmed that let-7a specifically represses the translation
of p66Shc, p52Shc, and p46Shc.
let-7a represses the expression of Shc by associating with
‘seedless’ interaction elements in the CR of p66Shc mRNA
By using the program RNA22, we identified three let-7a ‘seedless’
recognition elements (REs) – that is, sites of interaction lacking the
conventional 7–8 nucleotide ‘seed’ that typically defines microRNA–
mRNA interactions – in the CR of mRNA encoding p66Shc, p52Shc,
and p46Shc (Fig. S1). To confirm the association of let-7a with the CR
of Shc mRNA, HeLa cells were transfected with the reporter vectors
pSL-MS2, pSL-MS2-CR, pSL-MS2-3′UTR or pSL-MS2-CRD4 together
with the plasmid pSL-MS2-GFP-flag expressing the chimeric MS2-GFP-
flag protein (Fig. 2A). The CRD4 was derived from the CR fragment
mutating all three seedless REs of let-7a. This system allowed the
immunoprecipitation of microRNAs interacting with the p66Shc mRNA
fragments using anti-flag antibody (as the MS2-GFP-flag-MS2-CR, MS2-
GFP-flag-MS2-CRD4, orMS2-GFP-flag-MS2-3′UTR complex; Zhang et al.,
2012). The presence of microRNAs in the IP materials was assessed by RT-
qPCRanalysis.Asshown inFig. 2(B), the levelof let-7a in theMS2-GFP-flag-
MS2-CR complex was much higher than that in theMS2-GFP-flag-MS2-3′
UTR or MS2-GFP–MS2-CRD4 complexes. As negative controls, the abun-
dance of miR-30a or miR-203 in the MS2-GFP-flag-MS2-CR complex was
comparablewiththatdetectedinMS2-GFP-flag-MS2-3′UTRandMS2-GFP-
MS2-CRD4 complex. Therefore, let-7a interacts with the ‘seedless’ REs
within the CR of ShcmRNA.
Next, we tested if the interaction of let-7a with the Shc CR was
important for the regulation of Shc expression. We constructed pGL3-
derived reporters bearing the p66Shc fragments 3′UTR, CR, or the CR
fragment mutating the seedless interaction elements, as depicted in Figs
S1 and 2(C). IDH4 cells were cotransfected with a vector expressing
AS-let-7a or control antisense miRNA plus pGL3, pGL3-3′UTR, pGL3-CR,
pGL3-D1, pGL3-D2, pGL3-D3, or pGL3-D4 reporter vector along with
pRL-CMV control reporter, whereupon the firefly luciferase activity was
analyzed. As shown in Fig. 2(D), knockdown of let-7a increased the
luciferase activity from pGL3-CR by ~2.6-fold, but not from pGL3-3′UTR
or pGL3-CRD4. In addition, knockdown of let-7a was less effective in
elevating the luciferase activity of pGL3-CRD1 (~1.6-fold), pGL3-CRD2
(~1.9-fold), and pGL3-CRD3 (~1.1-fold). Together, interaction with the
seedless REs of Shc mRNA was essential for let-7a to repress Shc
translation.
The presence of an individual mRNA in polysomes and processing (P)
bodies are indicators of the efficiency of translation of that mRNA. We
therefore tested the presence of p66Shc mRNA in polysomes and
p-bodies of cells with silenced let-7a. As shown in Fig. S3, knockdown of
let-7a increased the presence of p66Shc mRNA in the polysome fraction
while it reduced the presence of MS2-CR chimeric transcripts in
P-bodies.
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Fig. 1 let-7a represses the translation of p66Shc. (A) IDH4 cells were transfected
with a vector expressing the pre-miRNA of let-7a, miR-30, or an empty vector.
Forty-eight hours later, cell lysate was prepared and subjected to Western blot
analysis using anti-p66Shc or anti-GAPDH antibody. (B) IDH4 cells were transfected
with a vector expressing AS-let-7a, AS-miR-30, or an empty vector. Forty-eight
hour after transfection, Western blot analysis was performed using anti-p66Shc or
anti-GAPDH antibody. (C) RNA samples described in panels (A,B) were subjected to
RT-qPCR analysis to assess the mRNA levels of p66Shc. (D) Cells described in (A)
(right) were incubated with L-[35S] methionine and L-[35S] cysteine (1 mCi mL1)
for 20 min, whereupon nascent p66Shc or GAPDH proteins were detected as
previously described. (E) HeLa cells were either individually transfected with a
vector expressing AS-let-7a (lane 2) or Ago2 (lane 3) shRNA or cotransfected with
both vectors (lane 4). Forty-eight hour after transfection, Western blotting analysis
was performed to assess the protein levels of Ago2, p66Shc, and GAPDH. All
Western blotting data are representative from three independent experiments. The
RT-qPCR data represent mean  SD from three independent experiments.
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Reduction of let-7a is accompanied by elevation of Shc
proteins in replicative senescence
Next, we assessed the levels of Shc proteins in early-passage (Young,
~PDL 27), middle-passage (middle, ~PDL 37), and late-passage (Senes-
cent, ~PDL 57) human diploid fibroblasts (2BS). As shown in Fig. 3(A),
Shc proteins were almost undetectable in Young 2BS cells, but they
increased in middle-passage cells and reached highest levels in senescent
cells; similarly, Shc proteins were also higher in senescent IDH4 cells
(Fig. 3B). The activity of p38MAPK (phospho-p38, p-p38) and the levels
of p16 increased with cellular senescence (Fig. 3A,B). let-7 was found to
suppress the expression of Ras, c-myc, E2F1, and CDC34, as well as to
elevate the expression of p21. However, both Ras and c-myc were
undetectable in either 2BS or IDH4 cells (data not shown); the levels of
CDC34 decreased ~80% in senescent 2BS and ~70% in senescent IDH4
cells; the levels of p21 increased in middle-passage (~6.5-fold) and late-
passage (~3.5-fold) 2BS cells as well as in senescent IDH4 cells (~3.3-fold;
Fig. 3A,B). Although the levels of E2F1 remained unchanged in
senescent 2BS cells, a remarkable reduction of E2F1 was observed in
senescent IDH4 cells (~90%). In agreement with the findings that
p66Shc is implicated in the production of intracellular ROS (Migliaccio
et al., 1999; Napoli et al., 2003), ROS levels were significantly increased
with the senescent process of both 2BS (P = 0.0175) and IDH4 cells
(P = 0.0072; Fig. 3C).
Using the cells described in Fig. 3(A,B), the levels of let-7a, miR-30,
U6, as well as p66Shc mRNA levels in 2BS and IDH4 cells progressing
toward senescence were determined by Northern blot analysis (Fig. 3D)
and by conventional RT-PCR analysis (Fig. 3E) respectively. In agreement
with previous findings (Marasa et al., 2010), the levels of let-7a were
reduced in middle-passage (~60%) and senescent (~80%) 2BS cells as
well as in senescent IDH4 cells (~90%). In contrast, the levels of miR-30,
U6, and p66Shc mRNA remained unchanged during senescence of 2BS
(Fig. 3D) and IDH4 cells (Fig. 3E). These results suggest that the
reduction of let-7a may contribute to the elevation of p66Shc, but not
to the alterations of CDC34, E2F1, or p21 during replicative senescence.
p66Shc reduces replicative lifespan of human diploid
fibroblasts
To address the role of p66Shc on cellular lifespan, p66Shc expression
was silenced in 2BS cells by stably transfecting a vector that expressed
p66Shc shRNA. This shRNA targets p66Shc, but not p52Shc or p46Shc
(Data S1). As shown in Fig. 4(A), knockdown of p66Shc reduced the
protein level of p66Shc (by ~80%), and p16 (by ~70%), as well as the
levels of phopho-p38 (p-p38, by ~40%). In contrast, the levels of
proteins p52Shc, p46Shc, and GAPDH remained unchanged. As a result,
knockdown of p66Shc reduced intracellular ROS levels (P = 0.01;
Fig. 4B), increased the S-phase compartment, reduced the G1 compart-
ment (Fig. 4C), and lowered SA b-gal activity (P = 0.0067; Fig. 4D).
After selection, the cells transfected with an empty vector essentially
stopped dividing by day 20 and increased ~4.4 PDL, while the cells with
silenced p66Shc stopped proliferating around day 30 and increased ~7.3
PDL (Fig. 4E). To further confirm the role of Shc proteins in replicative
lifespan, 2BS cells were stably transfected with vectors expressing
p66Shc, p52Shc, or p46Shc. As shown in Fig. S4(A), overexpression of
p66Shc elevated the levels of proteins p66Shc (~3.3 fold), p52Shc (~3.5-
fold), p46Shc (~3.0-fold), and p16 (~3.6-fold), as well as the levels of
phospho-p38 (~2.8-fold). As anticipated, cells overexpressing p66Shc
exhibited increased ROS levels (P = 0.0093; Fig. S4B), reduced S-phase
compartment, increased G1 compartment (Fig. S4C), increased SA b-gal
activity (P = 0.0003; Fig. S4D), and shortened replicative lifespan (Fig.
S4E). The activity of p38 (p-p38) was also elevated in cells overexpressing
p52Shc or p46Shc (Figs S5A and S6A). However, overexpression of
p52Shc or p46Shc did not significantly alter the levels of cellular ROS, cell
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Fig. 2 let-7 lowers p66Shc expression by interacting with the seedless recognition element (RE) in the coding region (CR) of p66Shc mRNA. (A) Schematic representation of
the reporter vectors used for the RNP IP assays, the CRD4 derived from the CR fragment mutated all three ‘seedless’ REs. (B) Forty-eight hour after cotransfection of HeLa
cells with pSL-GFP-MS2 and either pSL-MS2-CR, pSL-MS2-3′UTR, or pSL-MS2-CRD4, whole-cell lysates were prepared and subjected to IP assays using anti-GFP antibody
(5 lg mL1) or anti-IgG (5 lg mL1), RNA were prepared from the IP materials and subjected to qPCR analysis to assess the levels of let-7a, miR-30a, and miR-203. The
levels of microRNAs in pSL-MS2, pSL-MS2-CR, pSL-MS2-3′UTR, and pSL-MS2-CRD4 vector transfected cells are included (Input). Data represent the mean  SE from three
independent experiments. (C) Schematic representation of the pGL3-derived reporters used for reporter activity assays. (D) IDH4 cells were co-transfected with a vector
expressing AS-let-7a or control antisense miRNA plus pGL3, pGL3-3′UTR, pGL3-CR, pGL3-D1, pGL3-D2, pGL3-D3, or pGL3-D4 reporter vector along with pRL-CMV control
reporter. Forty-eight hour later, firefly luciferase activity was determined and normalized using renilla luciferase activity. Values represent the mean  SD from three
independent experiments.
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growth, as well as the replicative senescence and lifespan (Figs S5B–E
and S6B–E). These results suggest that p66Shc acts as a negative
regulator of the cellular lifespan, while p52Shc and p46Shc do not.
let-7a extends cellular lifespan by repressing p66Shc
expression
To address the impact of let-7a-p66Shc regulatory process upon
replicative senescence, let-7a function in 2BS cells was either repressed
or enhanced by stably transfecting cells with a vector expressing AS-let-
7a or the pre-let7a, respectively. As shown in Fig. 5, cells expressing
AS-let-7a increased the levels of p66Shc (~3.5-fold), p52Shc (~3.5-fold),
p46Shc (undetectable in control cells, but increased by AS-let-7a), p16
(~2.3-fold), and phspho-p38 (~2.2-fold; Fig. 5A), increased ROS levels
(P = 0.0034; Fig. 5B), reduced the S-phase compartment, increased the
G1 compartment (Fig. 5C), and increased SA b-gal activity (P = 0.0024;
Fig. 5D). After selection, AS-let-7a cells stopped proliferating around day
15, and increased ~2.7 PDL, while control cells stopped growing around
day 25 and increased ~4.8 PDL (Fig. 5E). In contrast, cells expressing pre-
let-7a exhibited reduced levels of Shc proteins (~65–70%), p16 (~50%),
and phospho-p38 (~55%; Fig. 6A), reduced ROS levels (P = 0.0015;
Fig. 6B), increased the S-phase cells and reduced G1-phase and SA-b-
gal-positive cells (P = 0.0080; Fig. 6C,D). Cells expressing pre-let-7a
continued to grow at day 37 after selection, with an increase in PDL
~6.4, while control cells stopped growing around day 25 after selection,
with an increase in ~4.0 PDL (Fig. 6E). In addition, 2BS cells expressing a
flag-tagged, frame-shifted p66Shc CR diminished the effect of let-7a in
repressing p66Shc, p52Shc, p46Shc, p16, and the activation of p38,
reducing ROS levels, promoting cell growth, delaying replicative senes-
cence, and extending cell lifespan (Fig. S7). However, expression of the
flag-p66Shc CRD4 was modest in rescuing the effect of expression of
pre-let-7a (Fig. S7). Together, let-7a promoted cell proliferation,
inhibited replicative senescence, and extended cell lifespan by repressing
the production of p66Shc.
Discussion
The findings presented in this study support the view that p66Shc
negatively regulates the lifespan of human diploid fibroblasts (Fig. 4), in
keeping with the finding that p66Shc deletion extends longevity in
mammals (Migliaccio et al., 1999). We have found that the elevation of
Shc proteins in replicative senescence is regulated at post-transcriptional
levels by let-7a (Figs 1–3, 5, 6 and S2). By repressing the translation of Shc
genes, let-7a extends the lifespan of human diploid fibroblasts (Figs 1, 5
and 6). Although the specific mechanisms by which let-7a represses the
translation of Shc proteins are not fully understood, our data suggest that
the association of let-7a with the seedless interaction elements located in
the CR of Shc mRNA (Fig. 2C) lowers the presence of Shc mRNA in
polysomes and enhances the recruitment of Shc mRNA into P-bodies (Fig.
S3). The effect of let-7a was specific, as inhibition of let7c, let-7d, miR-9,
miR-22, and miR-30 did not affect the levels of Shc proteins, while
inhibition of let-7b moderately increased the levels of Shc proteins (Fig.
S2). The let-7a-Shc regulatory process contributes at least in part to the
elevation of Shc proteins in senescent cells, because expression of the
Shc CR fragment antagonizes the effect of let-7a in regulating either Shc
expression or cellular lifespan (Fig. S7). Given that the expression of Shc
proteins in senescent cells is robustly elevated (Fig. 3) when let-7a levels
decline, the let-7a-Shc regulatory paradigmmay be in part responsible for
the elevation of Shc proteins in replicative senescence.
P66Shc, p52Shc, and p46Shc are adaptors for the Ras-MAPK
signaling pathway. In 2BS cells, p38 is activated by overexpression of
p66Shc, p52Shc, or p46Shc, or by knockdown of let-7a, while p38 is
inhibited by p66Shc knockdown or by let-7a overexpression (Figs 4A,
5A, 6A, S4A, S5A and S6A). Although the effects were most
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Fig. 3 Expression of let-7a and p66Shc in replicative senescence. (A) Western blot analysis of p66Shc, p52Shc, p46Shc, E2F1, p21, CDC34, p38, p-p38, p16, and GAPDH in
early- (~27 pdl), middle- (~37 pdl), and late-passage (~57 pdl) 2BS cells. (B) IDH4 cells were either cultured in the presence (Young, Y) or absence (Senescent, S) of
Dexamethasone (Dex) for 5 days, whereupon total protein was prepared for Western blot analyses to assess the expression levels of p66Shc, p52Shc, p46Shc, E2F1, p21,
CDC34, p38, p-p38, p16, and GAPDH. (C) Cellular ROS levels in cells described in (A,B) were analyzed. Data shown are the mean  SD from three independent experiments
and statistic significance was analyzed by Student’s t-test. (D,E) Total RNA prepared from cells described in (A,B) were used for Northern blot analysis (D) or semiquantitative
PCR (E) to assess the levels of let-7a, miR-30, p66Shc, and U6. ROS, reactive oxygen species.
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pronounced in the presence of active p66Shc, activation of p52Shc and
p46Shc also modestly elevated ROS levels and elevated the senescence-
associated b-galactosidase activity (Figs S5B and S6B). Given that
overexpression of p66Shc and that let-7a lowered the levels of all three
Shc isoforms (Figs S4 and 1), it is possible that p52Shc and p46Shc also
regulate replicative senescence. In addition, other let-7-regulated mRNAs
may also encode proteins involved in preventing senescence. Further
work is needed to identify the complete set of effectors through which
of let-7a impacts upon the cellular replicative lifespan.
MicroRNA-mediated gene regulation typically occurs through the
interaction of the microRNA with the 3′UTR of the target mRNA (Bartel,
2009). However, analysis using general bioinformatics tools (Targetscan,
miRanda, and microTv3.0), the p66Shc mRNA did not reveal any let-7
seed matches. Instead, our results indicate that seedless interaction
elements in the CR of p66Shc mediate the association between let-7a
and p66Shc mRNA and elicit the effects of let-7a (Fig. 2). MicroRNAs
influence the translation or turnover of mRNAs as part of a larger
molecular complex (the RISC) that includes Ago2 (Pratt & MacRae, 2009;
Czech & Hannon, 2011); as anticipated, Ago2/RISC was involved in the
let-7a-mediated regulation of Shc, because knockdown of Ago2
increased the levels of Shc proteins and diminished the effect of let-7
knockdown in elevating Shc expression (Fig. 1E).
p66Shc was described as a positive regulator of the proliferation of
human prostate cancer cells (Veeramani et al., 2005). In human diploid
fibroblasts, p66Shc may not promote cell growth, because elevated
p66Shc levels have been observed in senescent human diploid fibroblasts
(Fig. 3A) and in oxidative stress-induced senescence (Favetta et al., 2004).
Indeed, evidence obtained in the present study supports the view that
p66Shc acts as a negative regulator for cell growth (Figs 4C and S4C). On
theother hand, let-7a inhibits theproliferationofhumanglioblastoma (Lee
et al., 2011), human nonsmall cell lung tumor (Johnson et al., 2007;
Kumar et al., 2008; He et al., 2009), Burkitt lymphoma (Sampson et al.,
2007), breast cancer cells (Yu et al., 2007), and primary fibroblasts
(Legesse-Miller et al., 2009), through the repression of Ras, c-myc, E2F1,
and CDC34 as well as elevation of p21. However, these regulatory
processes by let-7amay not impact on replicative senescence, as Ras and c-
myc proteins were undetectable 2BS cells (not shown), and the reduction
of let-7a in senescent cells was not accompanied by elevation of E2F1 and
CDC34 or reduction of p21 (Fig. 3A,B).
The fact that let-7 represses proliferation of tumor cells but
promotes the growth of HDFs may reflect the view that cell senescence
contributes to tumorigenesis (Rodier & Campisi, 2011). In general,
genes highly expressed in senescent cells tend to show low expression
levels in cancer, and vice versa. Therefore, strategies to inhibit the
growth of tumor cells may also shorten the lifespan of normal cells by
inducing senescence, while strategies to extend cellular lifespan may
increase the risk of tumorigenesis. Targeting let-7a-p66Shc in cancer
may avoid this apparent dilemma, as extending cellular lifespan by
elevating let-7a or reducing p66Shc does not increase the risk of
tumorigenesis.
Experimental procedures
Cell culture and transfection
Human IDH4 fibroblasts were generously provided by J. W. Shay and
cultured in Dulbecco’s modified Eagle’s medium supplemented with
10% fetal bovine serum, 100 units mL1 penicillin, 100 lg mL1
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Fig. 4 p66Shc negatively regulates cellular lifespan. (A) 2BS cells were stably transfected with a vector expressing p66Shc shRNA. The levels of p66Shc, p38, p-p38, p16,
and GAPDH were assessed by Western blotting. (B) reactive oxygen species (ROS) levels were measured in cells treated as described in (A). (C,D) Cells described in (A) were
used for FACS analysis (C) and SA-b-gal analysis (D). The results of SA-b-gal and ROS analysis are shown as the means  SD and analyzed for statistical significance by
Student’s t-test. (E) After selection, 1 9 105 of cells described in (A) were cultured further, the cell numbers then were counted at times indicated, and the increase in PDLs is
represented.
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streptomycin, and dexamethasone (Dex, 1 lg mL1) for constitutive
expression of SV40 large T-antigen to suppress senescence and
stimulate proliferation (Chang et al., 2010). Early- [Proliferating, Young,
~27 population doublings (pdl)], middle- (37 pdl), and late-passage
(Senescent, ~57 pdl) human diploid 2BS fibroblasts (National Institute of
Biological Products, Beijing, China), and HeLa cells were cultured in
Dulbecco’s modified Eagle’s medium (Invitrogen, Grand Island, NY, USA)
supplemented with 10% fetal bovine serum, 100 units mL1 penicillin,
and 100 lg mL1 streptomycin, at 37°C in 5% CO2. All plasmids were
transfected using lipofectamine 2000 (Invitrogen) and collected 48–72 h
after transfection for further analysis. To establish 2BS cells stably
expressing pre-let-7, AS-let-7a, p66Shc, p52Shc, p46Shc, or p66Shc
shRNA, cells (~25 pdl) were transfected by lipofectamine 2000, selected by
the G418 reagent (300 lg mL1; Invitrogen) for 3–4 weeks, and main-
tained in medium supplemented with 50 lg mL1 G418.
RNA isolation, Northern blot, and PCR analysis
Total cellular RNA was prepared using the RNeasy Mini Kit (Qiagen,
Hilden, Germany). Northern blot analysis was performed as described by
Jing et al. (2005). For reverse-transcription (RT) followed by real-time,
quantitative (q)PCR or semiquantitative PCR analysis of p66Shc and
GAPDH, primers were described in ‘Supporting Information’. The primers
for qPCR or semiquantitative PCR analysis of let-7a, miR-30, and U6 were
from Ambion (Austin, TX, USA).
Constructs and reporter gene assays
All vectors were constructed as described in ‘Supporting Information’.
For reporter gene assays, each of the pGL3-derived vectors was
cotransfected with pRL-CMV vector by Lipofectamine 2000 (Invitrogen).
Forty-eight hour after transfection, cell lysates were collected and the
firefly and renilla luciferase activities were measured with a double
luciferase assay system (Promega, Madison, WI, USA) following the
manufacturer’s instructions. All firefly luciferase measurements were
normalized to renilla luciferase measurements from the same sample.
Western blot analysis
Western blot analysis was performed as described (Chang et al.,
2010). Monoclonal anti-GAPDH, polyclonal anti-p66Shc was from BD
Biosciences (San Jose, CA, USA), Monoclonal anti-E2F1, anti-p21, anti-
CDC34, and anti-p38, as well as polyclonal anti-p-p38 and p16 were
from Santa Cruz (Santa Cruz, CA, USA). After secondary antibody
incubation, signals were detected by SuperSignal WestPico Chemilumi-
nescent Substrate (Pierce, Rockford, IL, USA) following the manufac-
turer’s instruction and quantitated by densitometric analysis with
IMAGEMASTER VDS software (Amersham Biosciences, Freiburg, Germany).
Analysis of nascent protein and RNP IP assays
Nascent protein analysis was performed as described in ‘Supporting
Information’. For RNP IP assays, HeLa Cells were cotransfected with
reporter pSL-MS2 or pSL-MS2-CR along with the pSL-flag-MS2-GFP;
48 h later, cell lysates then were prepared and subjected to immuno-
precipitation assays by using monoclonal antiflag antibody (Sigma, St.
Louis, MO, USA). The IP materials were washed twice with stringent
buffer (100 mM Tris-HCI, pH 7.4, 500 mM LiCI, 0.1% Triton X-100, 1 mM
DTT, 2 lg mL1 leupeptin, 2 lg mL1 aprotinin, 1 mM phenylmethyl-
sulfonyl fluoride), and twice with the IP buffer. RNA was isolated from
the IP materials and analyzed by RT-qPCR to assess the levels of
microRNAs (Zhang et al., 2012).
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Fig. S1 Schematic representation depicting the coding region (CR) and
mutants of Src family mRNA.
Fig. S2 let-7a specifically represses the expression of p66Shc.
Fig. S3 let-7a inhibits the loading of p66Shc onto the p bodies but promotes
the presence of p66Shc in the polysome.
Fig. S4 Overexpression of p66Shc shortens the life span and accelerates the
replicative senescence of HDFs.
Fig. S5 Overexpression of p52Shc does not influence replicative senescence
and life span.
Fig. S6 Overexpression of p46Shc does not influence replicative senescence
and life-span.
Fig. S7 Ectopic expression of p66Shc CR fragment rescues the effect of let-7a
on repressing p66Shc expression and extending the cellular life span.
Data S1 Experimental procedures.
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